Yuri Matteo Falzone
Overview
Explore the profile of Yuri Matteo Falzone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zambon A, Falzone Y, Bolino A, Previtali S
Cell Mol Life Sci
. 2024 Jul;
81(1):308.
PMID: 39060715
No abstract available.
2.
Bertini A, Gentile L, Cavallaro T, Tozza S, Saveri P, Russo M, et al.
J Neurol Neurosurg Psychiatry
. 2024 Jun;
96(1):47-53.
PMID: 38839277
Background: We aimed to investigate the clinical features of a large cohort of patients with myelin protein zero ()-related neuropathy, focusing on the five main mutation clusters across Italy. Methods:...
3.
Doneddu P, Cocito D, Fazio R, Benedetti L, Peci E, Liberatore G, et al.
J Neurol Neurosurg Psychiatry
. 2024 May;
95(9):838-844.
PMID: 38729746
Background: To evaluate the efficacy of rituximab in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients not responding to conventional immune therapies. Methods: An open-label, prospective exploratory study was conducted with intravenous...
4.
Sorrenti B, Laurini C, Bosco L, Strano C, Scarlato M, Gastaldi M, et al.
Eur J Neurol
. 2024 May;
31(7):e16306.
PMID: 38716750
Background And Purpose: This study was undertaken to highlight neonatal Fc receptor inhibition (efgartigimod) as a valuable therapeutic option for patients with refractory seronegative myasthenia gravis (MG) and to emphasize...
5.
Zambon A, Falzone Y, Bolino A, Previtali S
Cell Mol Life Sci
. 2024 Apr;
81(1):198.
PMID: 38678519
Neuromuscular diseases encompass a heterogeneous array of disorders characterized by varying onset ages, clinical presentations, severity, and progression. While these conditions can stem from acquired or inherited causes, this review...
6.
Domi T, Schito P, Sferruzza G, Russo T, Pozzi L, Agosta F, et al.
J Neurol
. 2023 Nov;
271(3):1342-1354.
PMID: 37930481
Background And Objectives: Amyotrophic lateral sclerosis associated with mutations in SOD1 (SOD1-ALS) might be susceptible to specific treatment. The aim of the study is to outline the clinical features of...
7.
Bertini A, Manganelli F, Fabrizi G, Schenone A, Santoro L, Cavallaro T, et al.
J Neurol Neurosurg Psychiatry
. 2023 Nov;
95(5):434-441.
PMID: 37918904
Background: Shoe inserts, orthopaedic shoes, ankle-foot orthoses (AFOs) are important devices in Charcot-Marie-Tooth disease (CMT) management, but data about use, benefits and tolerance are scanty. Methods: We administered to Italian...
8.
Cerri F, Gentile F, Clarelli F, Santoro S, Falzone Y, Dina G, et al.
Front Oncol
. 2022 Oct;
12:974751.
PMID: 36226068
Although inflammation appears to play a role in neurolymphomatosis (NL), the mechanisms leading to degeneration in the peripheral nervous system are poorly understood. The purpose of this exploratory study was...
9.
Falzone Y, Bosco L, Sferruzza G, Russo T, Vabanesi M, Signorelli C, et al.
Acta Biomed
. 2022 Aug;
93(4):e2022212.
PMID: 36043970
Restrictions to human mobility had a significant role in limiting SARS-CoV-2 spread. It has been suggested that seasonality might affect viral transmissibility. Our study retrospectively investigates the combined effect that...
10.
Falzone Y, Domi T, Mandelli A, Pozzi L, Schito P, Russo T, et al.
Eur J Neurol
. 2022 Mar;
29(7):1930-1939.
PMID: 35263489
Background And Purpose: This study was undertaken to determine the diagnostic and prognostic value of a panel of serum biomarkers and to correlate their concentrations with several clinical parameters in...